A clustering analysis of lipoprotein diameters in the metabolic syndrome

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Frazier Wood, Alexis C ^a   Glasser, Stephen ^b   Garvey, W Timothy ^c   Kabagambe, Edmond K ^a   Borecki, Ingrid B ^d   Tiwari, Hemant K ^a   Tsai, Michael Y ^e   Hopkins, Paul N ^f   Ordovas, Jose M ^g,h,i   Arnett, Donna K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g TUFTS UNIVERSITY   (United States)

^h CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

ⁱ IMDEA FOOD INSTITUTE   (Spain)

Author keywords

fasting glucose; GOLDN; hypertension; hypertriglyceridemia; insulin resistance; latent class analysis; lipoprotein particle diameter; Metabolic Syndrome; nuclear resonance spectroscopy; waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CLUSTER ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHENOTYPE; AGED; BLOOD; CHEMISTRY; MIDDLE AGED;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; HUMANS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE;

EID: 83655196872     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-237     Document Type: Article

References (19)

1. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 5 10.1161/CIRCULATIONAHA.109.192644 19805654
2. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD, Arteriosclerosis, Thrombosis, and Vascular 2001 21 2051 8 10.1161/hq1201.100257 (Pubitemid 34219761)
3. Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the Metabolic Syndrome. Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Ordovas JM, Arnett DK, Lipids in Health and Disease 10 1 143
4. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y, Diabetes 2003 52 453 62 12540621 (Pubitemid 36173203)
5. Relationship of LDL size to insulin sensitivity in normoglycemic men. Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M, Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1447 53 10.1161/01.ATV.17.7.1447 9261279 (Pubitemid 27329872)
6. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B, Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2140 7 10.1161/01.ATV.20.9.2140 10978261
7. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PWF, D'Agostino RB, Vasan RS, Robins SJ, Circulation 2006 113 1 20 9 16380547 (Pubitemid 43958484)
8. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV, Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 2713 20 10.1161/01.ATV.17.11.2713 9409247 (Pubitemid 28016013)
9. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R, Diabetes 1990 39 1527 33 10.2337/diabetes.39.12.1527 2245877
10. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP, Circulation 2000 102 179 84 10889128 (Pubitemid 30451774)
11. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G, Diabetes Care 2002 25 971 6 10.2337/diacare.25.6.971 12032101 (Pubitemid 41110480)
12. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD, Metabolism 2005 54 264 70 10.1016/j.metabol.2004.09.002 15690322 (Pubitemid 40174857)
13. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT, Diabetes Care 2004 27 978 83 10.2337/diacare.27.4.978 15047659 (Pubitemid 38420225)
14. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM, Circulation 111 3465 72
15. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopkins PN, Glasser SP, et al. Atherosclerosis 2009 203 633 9 10.1016/j.atherosclerosis.2008.08.005 18804210
16. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Lai CQ, Arnett DK, Corella D, Straka RJ, Tsai MY, Peacock JM, Adiconis X, Parnell LD, Hixson JE, Province MA, Ordovas JM, Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1417 25 10.1161/ATVBAHA.107.140103 17431185 (Pubitemid 46809433)
17. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Jeyarajah EJ, Cromwell WC, Otvos JD, Clinics in laboratory medicine 2006 26 4 847 70 10.1016/j.cll.2006.07.006 17110242 (Pubitemid 44716510)
18. A SAS procedure based on mixture models for estimating developmental trajectories. Jones BL, Nagin Roeder KDS, Sociological Methods & Research 2010 29 374 93 22188849
19. Latent Class Growth Modelling: A Tutorial. Andruff H, Carraro N, Thompson A, Gaudreau P, Tutorials in Quantitative Methods for Psychology 2009 5 1 11 24